Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
申请人:Boehringer Ingelheim Pharma GmbH & Co. KG
公开号:US20040138215A1
公开(公告)日:2004-07-15
The present invention relates to substituted xanthines of general formula
1
the tautomers, the stereoisomers, the mixtures thereof, the prodrugs thereof and the salts thereof, which have valuable pharmacological properties, particularly an inhibitory effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
本发明涉及通式1的取代黄嘌呤,包括其互变异构体、立体异构体、混合物、前药及其盐,该类化合物具有有价值的药理学性质,特别是对二肽基肽酶-IV(DPP-IV)酶活性具有抑制作用。